{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T06:31:46Z","timestamp":1773297106642,"version":"3.50.1"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,9,6]],"date-time":"2019-09-06T00:00:00Z","timestamp":1567728000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.biopha.2019.109438","type":"journal-article","created":{"date-parts":[[2019,9,18]],"date-time":"2019-09-18T05:31:06Z","timestamp":1568784666000},"page":"109438","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"special_numbering":"C","title":["LncRNA FOXD3-AS1 promotes proliferation, invasion and migration of cutaneous malignant melanoma via regulating miR-325\/MAP3K2"],"prefix":"10.1016","volume":"120","author":[{"given":"Xige","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanhua","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhengjuan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingli","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.biopha.2019.109438_bib0005","first-page":"145","article-title":"Cutaneous malignant melanoma: pathology and management","volume":"20","author":"Dewar","year":"2002","journal-title":"Surgery"},{"issue":"2","key":"10.1016\/j.biopha.2019.109438_bib0010","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1046\/j.1365-2133.2000.03651.x","article-title":"Acral cutaneous melanoma in caucasians: clinical features, histopathology and prognosis in 112 patients","volume":"143","author":"Kuchelmeister","year":"2015","journal-title":"Br. J. Dermatol."},{"issue":"4","key":"10.1016\/j.biopha.2019.109438_bib0015","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1080\/000155598441882","article-title":"Increasing incidence of cutaneous malignant melanoma in children and adolescents 12-19 years of age in Sweden 1973-92","volume":"78","author":"Karlsson","year":"2008","journal-title":"Acta Derm. Venereol."},{"issue":"20","key":"10.1016\/j.biopha.2019.109438_bib0020","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1093\/jnci\/djg075","article-title":"A prospective study of pigmentation, sun exposure, and risk of cutaneous malignant melanoma in women","volume":"95","author":"Veier\u00f8d","year":"2003","journal-title":"J. Natl. Cancer Inst."},{"issue":"9","key":"10.1016\/j.biopha.2019.109438_bib0025","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1002\/bjs.1800780923","article-title":"Effect of initial biopsy procedure on prognosis in Stage 1 invasive cutaneous malignant melanoma: review of 1086 patients","volume":"78","author":"Lees","year":"2010","journal-title":"Br. J. Surg."},{"issue":"1","key":"10.1016\/j.biopha.2019.109438_bib0030","doi-asserted-by":"crossref","first-page":"730","DOI":"10.3390\/cancers3010730","article-title":"Metastatic Tumor Dormancy in Cutaneous Melanoma: Does Surgery Induce Escape?","volume":"3","author":"Tseng","year":"2011","journal-title":"Cancers"},{"issue":"6","key":"10.1016\/j.biopha.2019.109438_bib0035","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1002\/1097-0142(197806)41:6<2143::AID-CNCR2820410610>3.0.CO;2-9","article-title":"Combination hyperthermia and radiation therapy for cutaneous malignant melanoma","volume":"41","author":"Kim","year":"1978","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.biopha.2019.109438_bib0040","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.3892\/or.2014.3531","article-title":"Mitotic rate is a more reliable unfavorable prognosticator than ulceration for early cutaneous melanoma: a 5-year survival analysis","volume":"32","author":"Donizy","year":"2014","journal-title":"Oncol. Rep."},{"issue":"9","key":"10.1016\/j.biopha.2019.109438_bib0045","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1001\/archsurg.139.9.968","article-title":"Cutaneous melanoma in a multiethnic population: is this a different disease?","volume":"139","author":"Hemmings","year":"2004","journal-title":"Arch Surg"},{"issue":"Issue 1","key":"10.1016\/j.biopha.2019.109438_bib0050","first-page":"4075","article-title":"LncRNA GAS5 is a critical regulator of metastasis phenotype of melanoma cells and inhibits tumor growth in vivo","volume":"9","author":"Long","year":"2016","journal-title":"Onco. Ther."},{"issue":"9","key":"10.1016\/j.biopha.2019.109438_bib0055","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1016\/j.celrep.2016.04.018","article-title":"The lncRNA SLNCR1 mediates melanoma invasion through a conserved SRA1-like region","volume":"15","author":"Schmidt","year":"2016","journal-title":"Cell Rep."},{"issue":"8","key":"10.1016\/j.biopha.2019.109438_bib0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12032-016-0804-2","article-title":"LncRNA UCA1-miR-507-FOXM1 axis is involved in cell proliferation, invasion and G0\/G1 cell cycle arrest in melanoma","volume":"33","author":"Wei","year":"2016","journal-title":"Med. Oncol."},{"issue":"10","key":"10.1016\/j.biopha.2019.109438_bib0065","doi-asserted-by":"crossref","DOI":"10.1096\/fj.201700091R","article-title":"Long noncoding RNA FOXD3-AS1 regulates oxidative stress-induced apoptosis via sponging microRNA-150","volume":"31","author":"Zhang","year":"2017","journal-title":"FASEB J."},{"issue":"10","key":"10.1016\/j.biopha.2019.109438_bib0070","first-page":"4106","article-title":"Down-regulation of long non-coding RNA FOXD3 antisense RNA 1 (FOXD3-AS1) inhibits cell proliferation, migration, and invasion in malignant glioma cells","volume":"8","author":"Chen","year":"2016","journal-title":"Am. J. Transl. Res."},{"issue":"2","key":"10.1016\/j.biopha.2019.109438_bib0075","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/s41419-018-0275-9","article-title":"The long non-coding RNA FOXD2-AS1 promotes bladder cancer progression and recurrence through a positive feedback loop with Akt and E2F1","volume":"9","author":"Su","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.biopha.2019.109438_bib0080","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.gene.2017.12.026","article-title":"Long non-coding RNA FOXD2-AS1 aggravates nasopharyngeal carcinoma carcinogenesis by modulating miR-363-5p\/S100A1 pathway","volume":"645","author":"Chen","year":"2018","journal-title":"Gene"},{"issue":"3","key":"10.1016\/j.biopha.2019.109438_bib0085","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.ymthe.2017.12.017","article-title":"Risk-associated long noncoding RNA FOXD3-AS1 inhibits neuroblastoma progression by repressing PARP1-Mediated activation of CTCF","volume":"26","author":"Zhao","year":"2018","journal-title":"Mol. Ther."},{"issue":"10","key":"10.1016\/j.biopha.2019.109438_bib0090","first-page":"4106","article-title":"Down-regulation of long non-coding RNA FOXD3 antisense RNA 1 (FOXD3-AS1) inhibits cell proliferation, migration, and invasion in malignant glioma cells","volume":"8","author":"Chen","year":"2016","journal-title":"Am. J. Transl. Res."},{"issue":"11","key":"10.1016\/j.biopha.2019.109438_bib0095","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1016\/j.celrep.2016.11.055","article-title":"Functional mutations form at CTCF-Cohesin binding sites in melanoma due to uneven nucleotide excision repair across the motif","volume":"17","author":"Poulos","year":"2016","journal-title":"Cell Rep."},{"issue":"2","key":"10.1016\/j.biopha.2019.109438_bib0100","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1046\/j.1365-2559.2001.01066.x","article-title":"S100 expression in cutaneous scars: a potential diagnostic pitfall in the diagnosis of desmoplastic melanoma","volume":"38","author":"Robson","year":"2010","journal-title":"Histopathology"},{"issue":"11","key":"10.1016\/j.biopha.2019.109438_bib0105","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1093\/carcin\/bgx082","article-title":"Herbacetin suppresses cutaneous squamous cell carcinoma and melanoma cell growth by targeting AKT and ODC","volume":"38","author":"Kim","year":"2017","journal-title":"Carcinogenesis"},{"issue":"12","key":"10.1016\/j.biopha.2019.109438_bib0110","doi-asserted-by":"crossref","first-page":"21889","DOI":"10.1002\/jcp.28752","article-title":"Long noncoding RNA FOXD3-AS1 promotes colon adenocarcinoma progression and functions as a competing endogenous RNA to regulate SIRT1 by sponging miR-135a-5p","volume":"234","author":"Wu","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.biopha.2019.109438_bib0115","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.biopha.2015.01.013","article-title":"Expression of MicroRNA-325-3p and its potential functions by targeting HMGB1 in non-small cell lung cancer","volume":"70","author":"Yao","year":"2015","journal-title":"Biomed. Pharmacother."},{"issue":"10","key":"10.1016\/j.biopha.2019.109438_bib0120","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1007\/s00535-012-0576-1","article-title":"Genetic polymorphism of pri-microRNA 325, targeting SLC6A4 3\u2032-UTR, is closely associated with the risk of functional dyspepsia in Japan","volume":"47","author":"Arisawa","year":"2012","journal-title":"J. Gastroenterol."},{"issue":"1","key":"10.1016\/j.biopha.2019.109438_bib0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.21873\/anticanres.11282","article-title":"Clinical implications of high-mobility group Box-1 (HMGB1) and the receptor for advanced glycation end-products (RAGE) in cutaneous malignancy: a systematic review","volume":"37","author":"Nguyen","year":"2017","journal-title":"Anticancer Res."},{"issue":"15","key":"10.1016\/j.biopha.2019.109438_bib0130","doi-asserted-by":"crossref","first-page":"6387","DOI":"10.18632\/oncotarget.2201","article-title":"Overexpression of HMGB1 in melanoma predicts patient survival and suppression of HMGB1 induces cell cycle arrest and senescence in association with p21 (Waf1\/Cip1) up-regulation via a p53-independent, Sp1-dependent pathway","volume":"5","author":"Li","year":"2014","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.biopha.2019.109438_bib0135","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1038\/jid.2009.258","article-title":"Multiple pigmentation gene polymorphisms account for a substantial proportion of risk of cutaneous malignant melanoma","volume":"130","author":"Duffy","year":"2010","journal-title":"J. Invest. Dermatol."},{"issue":"4","key":"10.1016\/j.biopha.2019.109438_bib0140","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.3892\/ijo.2016.3637","article-title":"MicroRNA-186 suppresses cell proliferation and metastasis through targeting MAP3K2 in non-small cell lung cancer","volume":"49","author":"Huang","year":"2016","journal-title":"Int. J. Oncol."},{"issue":"7504","key":"10.1016\/j.biopha.2019.109438_bib0145","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/nature13320","article-title":"SMYD3 links lysine methylation of MAP3K2 to Ras-driven cancer","volume":"510","author":"Mazur","year":"2014","journal-title":"Nature"},{"issue":"28","key":"10.1016\/j.biopha.2019.109438_bib0150","doi-asserted-by":"crossref","first-page":"3864","DOI":"10.1038\/s41388-018-0249-5","article-title":"MEKK2 and MEKK3 suppress Hedgehog pathway-dependent medulloblastoma by inhibiting GLI1 function","volume":"37","author":"Lu","year":"2018","journal-title":"Oncogene"},{"issue":"9","key":"10.1016\/j.biopha.2019.109438_bib0155","doi-asserted-by":"crossref","first-page":"E1226","DOI":"10.1073\/pnas.1600813113","article-title":"MEKK2 mediates an alternative \u00ce\u00b2-catenin pathway that promotes bone formation","volume":"113","author":"Greenblatt","year":"2016","journal-title":"Proc. Nat. Acad. Sci."},{"key":"10.1016\/j.biopha.2019.109438_bib0160","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.phrs.2016.12.009","article-title":"Allosteric MEK1\/2 inhibitors including cobimetanib and trametinib in the treatment of cutaneous melanomas","volume":"117","author":"Roskoski","year":"2017","journal-title":"Pharmacol. Res."},{"issue":"17","key":"10.1016\/j.biopha.2019.109438_bib0165","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1038\/onc.2012.229","article-title":"Beta-catenin inhibits melanocyte migration but induces melanoma metastasis","volume":"32","author":"Gallagher","year":"2013","journal-title":"Oncogene"},{"issue":"62","key":"10.1016\/j.biopha.2019.109438_bib0170","doi-asserted-by":"crossref","first-page":"106026","DOI":"10.18632\/oncotarget.22523","article-title":"RTL1 promotes melanoma proliferation by regulating Wnt\/\u03b2-catenin signalling","volume":"8","author":"Fan","year":"2017","journal-title":"Oncotarget"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332219333025?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332219333025?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T11:42:05Z","timestamp":1760096525000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332219333025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":34,"alternative-id":["S0753332219333025"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2019.109438","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"LncRNA FOXD3-AS1 promotes proliferation, invasion and migration of cutaneous malignant melanoma via regulating miR-325\/MAP3K2","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2019.109438","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"109438"}}